ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 013,68
-0,55%
Dow Jones
38 852,86
-0,55%
DAX
18 602,39
-0,44%
Brent Oil
84,595
0,32%
Bitcoin
67 965,36
-0,48%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. AbSci Corporation (ABSI)

  7. AbSci Corporation (ABSI) Actualités

ABSI

AbSci (ABSI)

AbSci Corporation
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ABSI
DateHeureSourceTitreSymboleSociété
28/05/202414h00GlobeNewswire Inc.Absci to Participate in the Goldman Sachs 45th Annual Global Healthcare ConferenceNASDAQ:ABSIAbSci Corporation
14/05/202413h35Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ABSIAbSci Corporation
14/05/202413h32Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABSIAbSci Corporation
14/05/202413h30GlobeNewswire Inc.Absci Reports Business Updates and First Quarter 2024 Financial and Operating ResultsNASDAQ:ABSIAbSci Corporation
16/04/202414h00GlobeNewswire Inc.Absci to Report Business Updates and First Quarter 2024 Financial and Operating Results on May 14, 2024NASDAQ:ABSIAbSci Corporation
28/03/202421h05GlobeNewswire Inc.Absci to Participate in the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:ABSIAbSci Corporation
21/03/202412h30GlobeNewswire Inc.Absci Reports Business Updates and Fourth Quarter and Full Year 2023 Financial and Operating ResultsNASDAQ:ABSIAbSci Corporation
01/03/202422h01GlobeNewswire Inc.Absci Announces Closing of Public Offering of Common Stock Including Full Exercise of the Underwriters’ Option to Purchase Additional SharesNASDAQ:ABSIAbSci Corporation
28/02/202414h34Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ABSIAbSci Corporation
28/02/202404h20GlobeNewswire Inc.Absci Announces Pricing of Public Offering of Common StockNASDAQ:ABSIAbSci Corporation
27/02/202422h01GlobeNewswire Inc.Absci Announces Proposed Public Offering of Common StockNASDAQ:ABSIAbSci Corporation
21/02/202413h30GlobeNewswire Inc.Absci Initiates IND-Enabling Studies for ABS-101, a Potential Best-in-Class Anti-TL1A Antibody de novo Designed and Optimized Using Generative AINASDAQ:ABSIAbSci Corporation
20/02/202414h00GlobeNewswire Inc.Absci to Participate in Upcoming Investor ConferencesNASDAQ:ABSIAbSci Corporation
14/02/202400h16Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ABSIAbSci Corporation
06/02/202401h14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABSIAbSci Corporation
10/01/202413h30GlobeNewswire Inc.Absci Appoints Professor Sir Mene Pangalos to its Board of DirectorsNASDAQ:ABSIAbSci Corporation
08/01/202413h00GlobeNewswire Inc.Absci to Present Preclinical Data for ABS-101, A Potential Best-in-Class Anti-TL1A Antibody Development Program, at 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:ABSIAbSci Corporation
04/01/202422h57Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ABSIAbSci Corporation
03/01/202414h00GlobeNewswire Inc.Absci to Participate in the 26th Annual Needham Growth ConferenceNASDAQ:ABSIAbSci Corporation
28/12/202314h00GlobeNewswire Inc.Absci to Participate in the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:ABSIAbSci Corporation
20/12/202313h30GlobeNewswire Inc.Absci and PrecisionLife Announce Strategic R&D Partnership to Jointly Develop AI-Enabled Drug PipelineNASDAQ:ABSIAbSci Corporation
04/12/202316h41Dow Jones NewsAbsci Shares Rise 27% After Announcing Collaboration With AstraZenecaNASDAQ:ABSIAbSci Corporation
04/12/202313h30GlobeNewswire Inc.Absci Announces Collaboration with AstraZeneca to Advance AI-Driven Oncology CandidateNASDAQ:ABSIAbSci Corporation
15/11/202314h00GlobeNewswire Inc.Absci to Participate in the Piper Sandler 35th Annual Healthcare ConferenceNASDAQ:ABSIAbSci Corporation
14/11/202322h05GlobeNewswire Inc.Absci Reports Business Updates and Third Quarter 2023 Financial and Operating ResultsNASDAQ:ABSIAbSci Corporation
14/11/202308h16Business WireAlmirall and Absci announce AI drug discovery partnership to rapidly develop novel treatments for dermatological diseasesNASDAQ:ABSIAbSci Corporation
21/09/202314h00GlobeNewswire Inc.Absci Announces Speaker Lineup for Inaugural R&D Day, Including Renowned Global Business Leader Sandi Peterson and VP of Applied Research at NVIDIA Jonathan CohenNASDAQ:ABSIAbSci Corporation
06/09/202314h00GlobeNewswire Inc.Absci to Host R&D Day on October 4, 2023NASDAQ:ABSIAbSci Corporation
14/08/202314h02GlobeNewswire Inc.Absci Reports Business Updates and Second Quarter 2023 Financial and Operating ResultsNASDAQ:ABSIAbSci Corporation
14/08/202314h00GlobeNewswire Inc.Absci Appoints Zach Jonasson, Ph.D., as Chief Financial Officer and Chief Business OfficerNASDAQ:ABSIAbSci Corporation
 Showing the most relevant articles for your search:NASDAQ:ABSI

Dernières Valeurs Consultées

BIT
P1T6P5
BNP Paribas Issuance
BOV
D1OW34Q
Dow
BIT
P1U7F1
BNP Paribas Issuance
COIN
ZATEUR
TG
FRA
Fraport
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés